



Article  (Published Version)
http://sro.sussex.ac.uk
Stoneham, Simon M, Cantillon, Daire M, Waddell, Simon J and Llewelyn, Martin J (2020) 
Spontaneously occurring small-colony variants of staphylococcus aureus show enhanced 
clearance by THP-1 macrophages. Frontiers in Microbiology, 11 (1300). pp. 1-8. ISSN 1664-302X 
This version is available from Sussex Research Online: http://sro.sussex.ac.uk/id/eprint/91563/
This document is made available in accordance with publisher policies and may differ from the 
published  version or from the version of record. If you wish to cite this item you are advised to 
consult the publisher’s version. Please see the URL above for details on accessing the published 
version. 
Copyright and reuse: 
Sussex Research Online is a digital repository of the research output of the University.
Copyright and all moral rights to the version of the paper presented here belong to the individual 
author(s) and/or other copyright owners.  To the extent reasonable and practicable, the material 
made available in SRO has been checked for eligibility before being made available. 
Copies of full text items generally can be reproduced, displayed or performed and given to third 
parties in any format or medium for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge, provided that the authors, title and full bibliographic 
details are credited, a hyperlink and/or URL is given for the original metadata page and the 
content is not changed in any way. 
fmicb-11-01300 June 11, 2020 Time: 20:50 # 1
ORIGINAL RESEARCH




University of Colorado, United States
Reviewed by:
Paul M. Tulkens,
Catholic University of Louvain,
Belgium
Lorena Tuchscherr,





This article was submitted to
Microbial Immunology,
a section of the journal
Frontiers in Microbiology
Received: 03 February 2020
Accepted: 20 May 2020
Published: 12 June 2020
Citation:
Stoneham SM, Cantillon DM,
Waddell SJ and Llewelyn MJ (2020)
Spontaneously Occurring
Small-Colony Variants
of Staphylococcus aureus Show







Enhanced Clearance by THP-1
Macrophages
Simon M. Stoneham1,2* , Daire M. Cantillon2, Simon J. Waddell2 and Martin J. Llewelyn1,2
1 Department of Microbiology and Infection, Royal Sussex County Hospital, Brighton, United Kingdom, 2 Department
of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom
Staphylococcus aureus is a common cause of chronic and relapsing infection, especially
when the ability of the immune system to sterilize a focus of infection is compromised
(e.g., because of a foreign body or in the cystic fibrosis lung). Chronic infections are
associated with slow-growing colony phenotypes of S. aureus on solid media termed
small-colony variants (SCVs). Stable SCVs show characteristic mutations in the electron
transport chain that convey resistance to antibiotics, particularly aminoglycosides. This
can be used to identify SCVs from within mixed-colony phenotype populations of
S. aureus. More recently, populations of SCVs that rapidly revert to a “wild-type” (WT)
colony phenotype, in the absence of selection pressure, have also been described. In
laboratory studies, SCVs accumulate through prolonged infection of non-professional
phagocytes and may represent an adaptation to the intracellular environment. However,
data from phagocytic cells are lacking. In this study, we mapped SCV and WT colony
populations in axenic growth of multiple well-characterized methicillin-sensitive and
methicillin-resistant S. aureus strains. We identified SCVs populations on solid media
both in the presence and absence of gentamicin. We generated stable SCVs from
Newman strain S. aureus, and infected human macrophages with WT S. aureus
(Newman, 8325-4) and their SCV counterparts (SCV3, I10) to examine intracellular
formation and survival of SCVs. We show that SCVs arise spontaneously during axenic
growth, and that the ratio of SCV:WT morphology differs between strains. Exposure to
the intracellular environment of human macrophages did not increase formation of SCVs
over 5 days and macrophages were able to clear stable SCV bacteria more effectively
than their WT counterparts.
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INTRODUCTION
Staphylococcus aureus disease includes common acute skin
and soft tissue infections, acute toxin-mediated processes
(food poisoning, toxic shock), acute invasive infection such as
bacteremia and chronic infections, e.g., of bone and prosthetic
joints (Lowy, 1998). Despite rapid treatment with effective
antibiotics bacteremia is associated with high rates of metastatic
infection and death, and chronic infection is associated with high
rates of relapse (Kaasch et al., 2014). Slow-growing phenotypes of
S. aureus, so-called small-colony variants (SCVs), can be isolated
from chronic infections (Proctor et al., 2014). SCVs have been
hypothesized to represent a population of persisters that are less
immunogenic and more tolerant to antibiotic therapy, and thus
may contribute to treatment failure (Tuchscherr et al., 2010;
Proctor et al., 2014).
Small-colony variants form small colonies on solid media
[<1/10th the area of wild-type (WT) colonies], show reduced
pigmentation, and cause reduced haemolysis on blood agar
compared to their WT counterparts (von Eiff, 2008). The SCV
phenotype can either be stable over successive generations,
or rapidly revert to WT colony phenotype. Stable SCVs have
been isolated from patients with chronic infections, notably
osteomyelitis and cystic fibrosis (Proctor et al., 1995; Besier
et al., 2007), with characteristic mutations in components
affecting the electron transport chain (Besier et al., 2007;
Proctor et al., 2014). There is increasing evidence that
non-stable SCVs arise spontaneously at low (c. 1:10,000)
frequencies during axenic growth of S. aureus (Vulin et al.,
2018). Furthermore, it is possible to increase the proportion
of the population exhibiting a non-stable SCV phenotype
through exposure to antibiotics, particularly aminoglycosides
(Edwards, 2012; Vestergaard et al., 2016) and trimethoprim
(Kahl et al., 1998), and to conditions mimicking the intracellular
environment, including oxidative stress and low pH (Tuchscherr
et al., 2011; Leimer et al., 2016). Indeed, several studies
have examined intracellular persistence of SCVs within non-
professional phagocytes: endothelial cells (von Eiff et al., 1997;
Rollin et al., 2017), epithelial cells (Tuchscherr et al., 2011;
Leimer et al., 2016), and osteoblasts (Kalinka et al., 2014).
This has led to the hypothesis that SCVs represent an adapted
intracellular phenotype.
Although S. aureus has traditionally been considered to be
an extracellular pathogen, the idea that S. aureus can survive
intracellularly is not new; there is an increasing body of evidence
that S. aureus can survive within professional phagocytes,
notably macrophages (Kubica et al., 2008; Thwaites and Gant,
2011; Jubrail et al., 2016). Macrophages are key effectors of
the innate immune system; they are often the first immune
cells to encounter bacteria and are therefore likely to play an
important role in the initial recognition of, and response to,
infection (Rehm et al., 1980). An intracellular lifestyle may
protect bacteria from eradication by the immune system, reduce
exposure to antibiotics, and underlie dissemination of infection
(Thwaites and Gant, 2011). Recently it has been demonstrated
that infection of mice with leukocytes containing S. aureus led
to disseminated infection despite concurrent treatment with
antibiotics (Lehar et al., 2015). However, the significance of SCV
formation within these cells is unknown.
In the present study, we examined the dynamics of phenotype
switching between WT colonies and SCVs in vitro. Extended
axenic culture gave rise to distinct SCV populations on media
with and without gentamicin. We used growth in the presence
of gentamicin to identify a stable SCV (SCV3) from the parent
strain Newman allowing us to examine the growth kinetics
and antibiotic resistance pattern of SCV compared to WT
S. aureus. To test the hypothesis that SCVs are adapted for
intracellular survival, we adapted an in vitro infection model
using differentiated human THP-1 macrophages. In keeping with
previous studies (Jubrail et al., 2016), S. aureus was able to
persist within macrophages for 5 days. We used phenotypic
identification and growth in the presence of gentamicin to
identify SCVs arising from intracellular infection. We found
no evidence for enrichment of the SCV population during
macrophage infection. In addition, macrophages infected with
SCV3 showed lower intracellular numbers and more rapid
clearance of intracellular bacteria than those infected with the
parent strain Newman. Finally, to confirm that this phenomenon
was not restricted to Newman strain S. aureus, intracellular
infections were repeated with S. aureus 8325-4 and I10, a SCV
constructed through knockout of HemB (von Eiff et al., 1997).
This study represents the first examination of SCV selection and
survival within macrophages.
MATERIALS AND METHODS
Bacterial Strains and Culture
Staphylococcus aureus Newman was obtained from the PHE
culture collection. MRSA252, NCTC-8532, -12973, and -12493
were obtained from the microbiology department at the Royal
Sussex County Hospital. Strains 8325-4 and I10 were donated by
Dr. Iain Allen at the University of Brighton. All bacteria, with the
exception of I10, were grown to OD600 nm 0.6 in 30 mL Mueller–
Hinton Broth (MHB) (Sigma–Aldrich) in 250 mL vented flasks
on a shaking incubator at 185 r/min at 37◦C. I10 was grown
in Tryptic Soy Broth (Sigma–Aldrich) containing 2.5 µg/mL
erythromycin (Fisher) to maintain the Erm insertion. I10 was
generated as described previously by homologous recombination
of an erythromycin resistance cassette into the HemB gene
resulting in a stable SCV phenotype and has been shown to
persist intracellularly in bovine aortic endothelial cells (von
Eiff et al., 1997). Extended in vitro culture was performed in
250 mL vented flasks on a shaking incubator in 50 mL MHB
at 37◦C. Growth curves were conducted in 30 mL MHB or
RPMI 1640 (Fisher Scientific) supplemented with 10% heat-
inactivated fetal calf serum (HIFCS) (Pan Biotech) and 2 mM
L-glutamine (Fisher Scientific). OD600 nm was measured using
a Jenway 6305 Spectrophotometer in comparison to media
only controls.
Enumeration and Identification of SCVs
Small-colony variants were identified by their appearance on
solid media in either the presence or absence of gentamicin.
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SCVs were identified on antibiotic-free media [Luria-Bertani
agar (LA)] where SCV numbers were greater than or similar
to the number of WT colonies. In certain experiments, SCVs
were also identified on Mueller Hinton agar containing 2 µg/mL
gentamicin (MHA+G) as described in Edwards (2012), to allow
for enumeration of gentamicin resistant SCVs where WT colony
numbers greatly exceeded SCV number. SCVs identified this
way were phenotypically similar to SCVs described previously
(Proctor et al., 2006). Following identification of SCVs on
MHA+G, stability of mutants was determined by serial passage
on LA containing no antibiotics. Newman SCV3 was selected as
it was able to maintain its SCV phenotype through >8 passages
on antibiotic-free media.
Determination of Minimum Inhibitory
Concentrations
MICs were determined by microbroth dilution in MHB. Bacteria
were grown in MHB on a shaking incubator at 185 r/min until
they reached exponential phase ∼OD600 nm 0.6. Bacteria were
diluted to ∼5 × 105 cfu/mL then added to pre-prepared 96-well
plates containing either gentamicin, erythromycin, flucloxacillin,
rifampicin, or ofloxacin (Sigma); 96 well plates were prepared
by twofold serial dilution of antibiotics immediately prior
to the experiment. Each experiment was performed three
times in triplicate wells. Bacterial growth was determined by
measurement of OD600 nm on a Biotek synergy HT plate-reader
at either 24 h for WT Newman or 48 h for SCV3. The MIC was
defined as the minimum concentration of antibiotic required to
completely inhibit growth.
Cell Culture and Differentiation
The human monocytic leukemia cell line THP-1 was maintained
in RPMI 1640 supplemented with HIFCS and 2 mM L-glutamine.
Cells were split every 3–4 days to maintain a density of between
3 × 105 and 1 × 106 cells/mL. THP-1 cells were differentiated
using 100 nM phorbol 12-myristate 13-acetate (PMA) for 72 h
and plated at a density of 2 × 105 cells/mL in 24 well plates
to produce a terminally differentiated macrophage phenotype,
competent for intracellular killing (Daigneault et al., 2010). On
day 3, cells were washed once in supplemented RPMI-1640 and
allowed to rest for 5 days before infection.
Macrophage Challenge With S. aureus
Differentiated macrophages were challenged with different
strains of S. aureus at a multiplicity of infection (MOI) of
1. This method was modified from Jubrail et al. (2016). In
brief, frozen stocks of S. aureus were thawed, centrifuged at
13,000 r/min for 3 min and resuspended in supplemented RPMI-
1640 before 0.5 mL of bacterial suspension or fresh media was
added to experimental wells. Cells were allowed to phagocytose
bacteria for 3 h at 37◦C in 20% CO2. After 3 h extracellular
bacteria were removed by washing twice in warm supplemented
RPMI-1640. Any remaining extracellular bacteria were killed
by the addition of 20 µg/mL lysostaphin (Sigma) for 30 min.
Lysostaphin was used for elimination of extracellular bacteria
as it is not known as a potent inducer of SCVs and does not
enter mammalian cells (Kim et al., 2019). Killing of extracellular
bacteria was confirmed by control wells containing bacterial
suspension but no cells. After 30 min, cells were either lyzed or
media was replaced with RPMI containing 2 µg/mL lysostaphin.
At specified time points, cells were washed twice in PBS before
lysis with 250 µL 2% saponin (Sigma). After 12 min at 37◦C,
750 µL PBS was added to wells containing saponin and mixed
by vigorous pipetting; 100 µL lysates were serially diluted and
plated onto LA overnight or MHA+G for 48–72 h at 37◦C before
counting colony forming units. Macrophage experiments were
performed in triplicate.
Statistical Analysis
All graphs are represented as mean ± SD or SEM as specified in
the figure legend. Statistical analysis was performed using Prism
8 (GraphPad Software, San Diego, CA, United States). Statistical
significance was determined as P < 0.05. All statistical tests used
are listed in the figure legends.
RESULTS
SCVs Occur Spontaneously During
Axenic Culture of S. aureus
To assess the proportion of SCV and WT colonies detectable in
axenic culture of S. aureus, stationary phase (24 h culture) NCTC
12493, 8532, 8325-4, Newman, and MRSA 252 strains of S. aureus
were inoculated onto solid media containing gentamicin to select
for gentamicin-resistant SCVs [Mueller–Hinton agar containing
2 µg/mL gentamicin (MHA+G)], and antibiotic-free media to
enumerate WT colonies (LA) (Figure 1A). SCVs were identified
for all strains occurring at frequencies ranging from 1 × 10−4 to
2 × 10−2 (Figure 1B). Additionally, we observed quantitatively
different SCV populations between strains, notably a larger
proportion of SCVs were found in Newman compared to 8325-4
[9730 ± 994 vs 4960 ± 876 cfu/mL (P = 0.02)]. This difference
was found not to be significant when we corrected for multiple
comparisons (Figure 1A). Interestingly, there was a tendency for
strain 8532 to produce SCVs at a higher frequency (Figure 1A).
To examine the dynamics of the SCV population over time,
we extended culture of S. aureus strains 8325-4 and Newman
up to 7 days with the hypothesis that nutrient depletion and
acidification of the media would select for SCV formation by
favoring slow-growing phenotypes. Newman was examined as
it has previously been shown to persist within macrophages
and we hypothesized that this ability may be linked to its
ability to form SCVs in nutrient deplete and acidic conditions
(Jubrail et al., 2016).8325-4 has been used to generate SCVs
in vitro (von Eiff et al., 1997). We found that while the
proportion of gentamicin resistant SCVs did not increase,
a second population with an SCV phenotype that was not
gentamicin resistant was detectable on antibiotic-free media after
120 h at a frequency approaching that of WT (Figures 1C,D). At
120 h, S. aureus colonies showed significant phenotypic variation
on solid media (Figure 2A).
In order to examine the stability of the SCV phenotype,
Newman strain S. aureus was inoculated onto gentamicin
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FIGURE 1 | SCVs occur spontaneously during axenic growth of S. aureus. (A) Multiple strains of S. aureus were grown in Mueller Hinton Broth (MHB) for 24 h and
CFUs enumerated on media with (MHA+G) and without (LA) gentamicin to select SCV or wild-type colony morphologies, respectively. (B) The mean frequency of
SCVs to wild-type colonies. (C) Newman and (D) 8325-4 S. aureus strains were cultured in MHB for 7 days and CFUs enumerated on media with (MHA+G) and
without gentamicin (LA). After 120 h, a SCV population arose on media without gentamicin. Plots represent the mean of three independent cultures and error bars
represent the standard deviations of the mean. Differences in SCV numbers were analyzed by one-way ANOVA with Tukey’s post hoc test. ∗P < 0.05.
containing media (MHA+G). Small colonies that arose were
passaged onto gentamicin-free media (LA). Multiple colonies
were picked based on morphological characteristics (size and
pigmentation). Colonies demonstrated three different behaviors:
full reversion to WT, partial reversion, or a stable SCV phenotype
(Figure 2). One, termed SCV3, was selected for further work
as it demonstrated a stable phenotype over eight passages on
antibiotic-free media.
SCV3 Has a Phenotype Typical of Stable
SCVs
To characterize SCV3, we first examined its growth kinetics
compared to WT Newman strain S. aureus in MHB and RPMI
1640 (Figure 3). RPMI 1640 has a composition designed to mimic
human tissue fluid but also supports the growth of S. aureus.
As expected, SCV3 showed a markedly reduced doubling time
(124 vs 44 min) over 24 h compared to WT Newman, with
SCV3 only reaching an optical density in MHB of 0.8 ± 0.005
after 24 h compared to 5.4 ± 0.2 for WT. Second, we assessed
the antibiotic susceptibility of SCV3 and WT Newman by
microbroth dilution. Growth was measured by optical density
at 600 nm on a plate reader at 24 h for WT Newman and 48 h
for SCV3. Only the MIC for gentamicin was increased beyond
one dilution difference compared with the parent strain (Table 1)
(Clinical and Laboratory Standards Institute, 2012).
Intracellular Survival Within
Macrophages Does Not Select for SCVs
To test the hypothesis that SCVs represent an adapted
intracellular phenotype within professional phagocytes, we
examined selection for, and persistence of, SCVs within
THP-1 derived macrophages. PMA stimulated THP-1 derived
macrophages were infected with WT, Newman and 8325-
4 S. aureus, and their corresponding SCVs, SCV3, and I10
(Figures 4A,B). Intracellular killing of Newman was incomplete
up to 5 days (Figure 4A), with ∼2 log reduction in viable
intracellular bacteria over 120 h. 8325-4 showed considerable
variability in survival at 120 h (Figure 4B). The corresponding
SCVs were killed more effectively by macrophages. By day 5
intracellular numbers of SCV3 and I10 were markedly less than
those of WT Newman and 8325-4, respectively (Figures 4A,B).
Colonies cultured from intracellular bacteria were examined
for SCV phenotype on both antibiotic-free (LA) and gentamicin-
containing (MHA+G) media. Although a small population
of gentamicin-resistant SCVs was initially identified at 3.5 h
with Newman, this was not detectable at later time points
(Figure 4C), or at all in 8325-4 (Figure 4D). There was a
consistent increase in the proportion of gentamicin-sensitive
SCVs at 24 h (Figures 4C,D) coinciding with the highest rate of
intracellular killing. However, the proportion of these colonies fell
by the end of the experiment.
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FIGURE 2 | Identification of S. aureus SCVs on solid media. (A) SCVs were
identified by their appearance on Luria-Bertani agar (LA) generally appearing
to be <1/10th the size of wild-type colonies. SCVs selected on gentamicin
demonstrated either (B) full reversion, (C) partial reversion, or (D) no reversion
to wild-type following 24 h growth on non-selective media (LA). Images shown
are close-ups of drops on agar demonstrating different colony morphotypes
at 24 h.
FIGURE 3 | SCV3 shows altered growth kinetics to parent strain Newman
S. aureus. Newman and SCV3 were inoculated into MHB and RPMI-1640
and incubated on a shaking incubator at 37◦C for 24 h. Growth was
measured by optical density at 600 nm. Data points represent the mean of
three independent experiments. Error bars demonstrate standard deviation of
the mean.
To determine whether the intracellular environment might
exert selection pressure to cause SCV3 to revert to WT, we
measured changes in colony morphology over time in SCV3
isolated from the intracellular compartment. We found the
SCV phenotype and gentamicin resistance was maintained with
no significant difference in CFUs between colonies isolated on
gentamicin-containing and antibiotic-free media (Figure 4E).
DISCUSSION
Small-colony variant formation has been proposed as a
mechanism by which S. aureus evades the host immune response,
establishes chronic infection, and remains refractory to treatment
(Proctor et al., 2006). Recent findings suggest that SCV formation
may be a constitutive part of S. aureus growth, adopted as a









MICs were determined at 24 h for Newman and 48 h for SCV3. MICs of SCV3 and
wild-type were within one dilution, except for gentamicin that was used to select
SCV3. Values are derived from three biological replicates each of three technical
replicates. Where there was discrepancy between biological replicates, the value
shown is the mean with the standard deviation in parentheses.
bet-hedging strategy against changing environmental conditions
(Edwards, 2012).
In keeping with this hypothesis, we have confirmed previous
findings that SCVs arise at low frequencies during axenic
culture of all strains of S. aureus tested, in the absence of
obvious selection pressure. These observations mirror those
for other S. aureus strains following exposure to gentamicin
(Edwards, 2012; Vestergaard et al., 2016). Several mutations
conferring reduced aminoglycoside susceptibility have been
described in both clinically isolated and laboratory-constructed
SCVs (Schaaff et al., 2003). Gentamicin resistance provides a
useful selection tool for SCVs arising from disruption of the
electron transport chain (Schaaff et al., 2003; von Eiff et al.,
2006). Loss of membrane potential reduces susceptibility to the
heavily charged aminoglycoside molecule. Gentamicin selection
is particularly useful as it inhibits the growth of WT S. aureus
but allows for the continued growth of SCVs in mixed culture.
However, not all SCVs arising spontaneously will be gentamicin
resistant, particularly short-lived unstable SCVs. To address
this limitation and, in contrast to previous studies, we have
enumerated SCVs both on antibiotic-free media (LA) and on
gentamicin-containing media. We observed that in extended
culture, a population of gentamicin-sensitive SCVs arose to
magnitudes comparable to WT bacteria. This represents the first
description of mixed SCV populations, distinguishable by their
gentamicin sensitivity, arising spontaneously during prolonged
growth. Thus, these data support the prevailing hypothesis that
SCVs represent a compound phenotype of revertant and stable
morphotypes arising from multiple mechanisms rather than a
single regulatory or mutational switch (Kahl et al., 2016).
Small-colony variant identification on antibiotic-free media
has a significant limitation in that slow-growing colonies will not
be identified by the surface viable count method, in populations
of S. aureus where the majority of bacteria give rise to large
colonies. Large colonies will overwhelm SCVs present at low
frequencies. Automated plate readers and single cell imaging
have provided a useful way around this problem (Vulin et al.,
2018). Vulin et al. (2018) were able to demonstrate SCVs
arising due to delayed initiation of growth, rather than reduced
growth rate using this technique. In the present study, the viable
count method was able to identify SCVs on non-selective media
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FIGURE 4 | Intracellular survival within macrophages does not select for SCVs. Differentiated THP-1 macrophages were infected with different strains of S. aureus at
an MOI of 1. After 3 h, extracellular bacteria were removed by washing and by treatment with lysostaphin. Intracellular bacteria were plated onto media with
(MHA+G) or without (LA) gentamicin. Colony forming units of (A) Newman and corresponding SCV3 and (B) 8325-4 and its derivative SCV strain I10 were measured
over 5 days. Intracellular SCV3 numbers were significantly lower than that of Newman at day 5. At 5 days, no colonies of I10 were recovered on any media.
Enumeration of different colony phenotypes recovered from macrophages after 5 days infection with (C) Newman and (D) 8325-4. No SCVs were recovered on
MHA+G for 8325-4 and none beyond 3.5 h for Newman. A small population of SCVs was observed in the absence of gentamicin. (E) SCV3 did not revert to
wild-type colony morphology during intracellular infection. There was no significant difference between numbers of colonies on either media type. Data points
represent the mean of three separate experiments each with three technical replicates ± SEM. Means were compared by independent t-test. *P < 0.05, **P < 0.01.
when their number closely resembled that of WT, allowing for
enumeration at the same dilution.
We find statistically significant differences in the number
of SCVs produced by different SCV strains, notably NCTC
8532 produced significantly more SCVs than MRSA 252,
Newman, and 8325-4. The biological significance of this remains
unclear. It would be interesting to investigate whether these
differences are associated with an increased propensity to
establish chronic infection.
While SCV formation is promoted by conditions mimicking
the intracellular environment (Painter et al., 2015; Leimer et al.,
2016; Vulin et al., 2018), and SCVs appear to have a survival advan-
tage within non-professional phagocytes (von Eiff et al., 1997;
Tuchscherr et al., 2011; Kalinka et al., 2014; Leimer et al., 2016;
Rollin et al., 2017), there have been limited data available from
phagocytic cells. Three studies have examined intracellular killing
of SCVs within THP-1 macrophage-like cells over 72 h in
response to antibiotics (Barcia-Macay et al., 2006; Nguyen et al.,
2009; Sandberg et al., 2011; Painter et al., 2015). The behavior
of THP-1 macrophages varies greatly according to the extent of
differentiation (Daigneault et al., 2010). Thus, it is difficult to
draw conclusions from these experiments on macrophage killing
of SCVs. Indeed, the aim of these studies was to establish a stable
intracellular population that could be exposed to antibiotics; in
their control experiments extracellular bacteria were allowed to
persist and maintain an intracellular population. Intracellular
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survival of WT S. aureuswithin macrophages and neutrophils has
been demonstrated by several studies (Kubica et al., 2008; Painter
et al., 2015; Jubrail et al., 2016) and has been hypothesized to
represent a vehicle for dissemination of infection (Thwaites and
Gant, 2011). Lehar et al. (2015) showed that mice infected with
intracellular S. aureus still produced abscesses despite concurrent
treatment with antibiotics. Data examining SCV interactions
with phagocytes are far more limited. Painter et al. demonstrated
that SCVs were more likely to survive exposure to human
neutrophils than WT, despite similar levels of internalization
over 3 h (von Eiff et al., 2006). By contrast Tuchscherr et al.
(2011) found elimination of S. aureus from macrophage with
no evidence of SCV formation. Here, we have shown for the
first time that WT S. aureus has a survival advantage over SCVs
in THP-1 macrophages during prolonged infection. We used a
method based on that of Jubrail et al. (2016) who were able to
demonstrate intracellular survival of WT S. aureus in both THP-
1 and monocyte derived macrophages. Interestingly the rate of
killing is higher for Newman than SCV 3 (Figure 4A) implying
that early killing may favor SCVs consistent with previous
findings (Painter et al., 2015). Jubrail et al. (2016) demonstrated
a failure of lysosomal acidification in THP-1 macrophages
infected with S. aureus, while Staphylococcus epidermidis SCVs
have recently been shown to colocalize at higher rates within
lysosomes than their WT counterparts (Magryś et al., 2018); it
is possible that SCVs are unable to impair lysosomal acidification
to the same extent as their WT counterparts. Additionally, Jubrail
et al. (2016) demonstrated repeated cycles of macrophage lysis
and re-uptake which may be impaired in SCVs.
One characteristic feature of many studies examining
intracellular survival is the use of high MOI (c. 100) to achieve an
intracellular infection, which may not be representative of in vivo
host–pathogen interactions. Here we have used a low MOI of 1
to achieve intracellular persistence with the WT strain Newman,
hoping to prevent saturation of intracellular killing mechanisms
simply by weight of numbers.
Our study has several important limitations: We have
only examined the elimination of two SCV strains, one
arising from gentamicin selection (SCV3), a common feature
of clinically isolated SCVs, and one laboratory constructed
mutant (I10). It is difficult to generalize these findings to
all SCVs. Certainly intracellular survival of WT S. aureus is
strain specific (Strobel et al., 2016), this is not well described
for SCVs. Additionally, the behavior of THP-1 macrophages
in vitro may not be similar enough to tissue macrophages
in vivo, despite previous observations that THP-1 macrophages
and monocyte-derived macrophages responded similarly to
WT S. aureus (Jubrail et al., 2016).Nevertheless none of these
limitations undermine the fundamental observation that
THP-1 macrophages eliminated both gentamicin-selected and
laboratory-constructed SCVs more effectively than their WT
counterparts (Figures 4A,B) and infection with WT S. aureus did
not give rise to enrichment of the SCV population (Figures 4C,D).
Future studies are required to examine the interaction of SCVs
with macrophages in vivo.
CONCLUSION
Our data support previous findings that SCV formation appears
to be a constitutive part of S. aureus growth and that this gives rise
to mixed populations of gentamicin-sensitive and gentamicin-
resistant SCVs. While this process may play an important role in
tolerance to aminoglycosides, and establishing chronic infection,
we find no evidence for spontaneously arising SCVs having a
survival advantage over their WT counterparts within THP-
1 macrophages.
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